HALEY HOWARD: Open Payments
NPI 1740010024 · CALLAWAY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$932 in 55 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $14 · 2025 $932
Food & beverage: $932
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $234 |
| Supernus Pharmaceuticals, Inc. | 28 | $216 |
| MDD US Operations, LLC | 1 | $118 |
| Otsuka America Pharmaceutical, Inc. | 5 | $106 |
| Vanda Pharmaceuticals Inc. | 3 | $68 |
| Neurocrine BioSciences, Inc. | 2 | $58 |
| ACADIA Pharmaceuticals Inc | 1 | $48 |
| E.R. Squibb & Sons, L.L.C. | 2 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $34 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
Products named: Qelbree, VRAYLAR, REXULTI, FANAPT, INGREZZA, NUPLAZID, COBENFY, TRINTELLIX.
Industry payments across FL — which companies pay providers there.
